Free Trial

Edesa Biotech (EDSA) Stock Price, News & Analysis

Edesa Biotech logo
$2.45 +0.05 (+2.25%)
Closing price 03:57 PM Eastern
Extended Trading
$2.45 0.00 (-0.16%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Edesa Biotech Stock (NASDAQ:EDSA)

Key Stats

Today's Range
$2.26
$2.51
50-Day Range
$1.95
$2.45
52-Week Range
$1.55
$5.00
Volume
51,879 shs
Average Volume
20,424 shs
Market Capitalization
$17.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Strong Buy

Company Overview

Edesa Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

EDSA MarketRank™: 

Edesa Biotech scored higher than 44% of companies evaluated by MarketBeat, and ranked 755th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Edesa Biotech are expected to grow in the coming year, from ($1.75) to ($1.34) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Edesa Biotech is -1.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Edesa Biotech is -1.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Edesa Biotech has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.12% of the float of Edesa Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Edesa Biotech has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Edesa Biotech has recently decreased by 60.25%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Edesa Biotech does not currently pay a dividend.

  • Dividend Growth

    Edesa Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.12% of the float of Edesa Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Edesa Biotech has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Edesa Biotech has recently decreased by 60.25%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Edesa Biotech has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Edesa Biotech this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Edesa Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.60% of the stock of Edesa Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.50% of the stock of Edesa Biotech is held by institutions.

  • Read more about Edesa Biotech's insider trading history.
Receive EDSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EDSA Stock News Headlines

Zacks Small Cap Reduces Earnings Estimates for Edesa Biotech
EDSA: EB06 Manufacturing to be Completed by End of 2025…
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.tc pixel
Edesa Biotech Posts Narrower Loss in Q3
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
See More Headlines

EDSA Stock Analysis - Frequently Asked Questions

Edesa Biotech's stock was trading at $1.68 at the beginning of 2025. Since then, EDSA stock has increased by 46.1% and is now trading at $2.4540.

Edesa Biotech, Inc. (NASDAQ:EDSA) issued its quarterly earnings data on Friday, August, 8th. The company reported ($0.25) EPS for the quarter, topping analysts' consensus estimates of ($0.26) by $0.01.

Shares of Edesa Biotech reverse split before market open on Wednesday, October 11th 2023.The 1-7 reverse split was announced on Tuesday, October 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, October 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Shares of EDSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Edesa Biotech investors own include Pfizer (PFE), Ford Motor (F), Moderna (MRNA), Occidental Petroleum (OXY), Plug Power (PLUG), Advanced Micro Devices (AMD) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/08/2025
Today
8/28/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EDSA
CIK
1540159
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+107.9%
Consensus Rating
Strong Buy
Rating Score (0-4)
4.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.17 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-162.95%
Return on Assets
-60.33%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
18.96
Quick Ratio
18.96

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.70 per share
Price / Book
3.44

Miscellaneous

Outstanding Shares
7,040,000
Free Float
5,447,000
Market Cap
$16.93 million
Optionable
Not Optionable
Beta
0.27

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:EDSA) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners